Dr. Fabre joined TRISH December 2018 as the Senior Innovation Scientist to lead the Scientific Research Program. She works with the TRISH team, NASA, industry and academia to develop and maintain initiatives in biomedical research for space health. Of great interest will be to identify, test and develop research using human analogue models and implement a radiation countermeasures program for deep space flight.

Before joining TRISH, Dr. Fabre was the Microphysiological Systems (MPS) Lead at AstraZeneca and was part of the MPS Center of Excellence, Drug Safety and Metabolism. She worked with several key AZ members and external partners to develop how to best utilize MPS technology for drug development and screening. Other vital tasks included advisory roles in various MPS-relevant consortiums, including the NIH Tissue Chip Consortium and the IQ Consortium. Prior to joining AZ in 2016, she was the Scientific Program Manager for the Microphysiological Systems (or Organs-on-Chips) Initiative at NIH National Center for Advancing Translational Sciences (NCATS). This role included providing oversight on all MPS cooperative agreements, including members from FDA, DARPA, NIH and several academic institutions across the United States in addition to building public-private partnerships.
Dr. Fabre received her BS in Biology from the University of Wyoming, followed by her MS and PhD from Colorado State University in Cell and Molecular Biology. Prior to joining NCATS, she was at the NIH National Cancer Institute as a postdoctoral fellow in the Radiation Biology Branch. During her time at the NCI, Dr. Fabre was highly involved with training programs and was Chair of the NCI Fellows and Young Investigators Steering Committee and created the NCI Fellows Outreach Committee.